天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook--->CAS DataBase List--->343962-53-8

343962-53-8

343962-53-8 Structure

343962-53-8 Structure
IdentificationBack Directory
[Name]

Notoginsenoside T1
[CAS]

343962-53-8
[Synonyms]

Notoginsenoside T1
β-D-Glucopyranoside, (3β,6α,12β,20E)-24,25-epoxy-3,12,23-trihydroxydammar-20(22)-en-6-yl (9CI)
[Molecular Formula]

C36H60O10
[MOL File]

343962-53-8.mol
[Molecular Weight]

652.87
Chemical PropertiesBack Directory
[Melting point ]

131-133℃
[Boiling point ]

764.5±60.0 °C(Predicted)
[density ]

1.29±0.1 g/cm3 (20 ºC 760 Torr)
[pka]

12.91±0.70(Predicted)
Hazard InformationBack Directory
[Uses]

Notoginsenoside T1 is a dammarane glycoside from the acid hydrolysis product of the root saponins of Panax notoginseng.
[Definition]

ChEBI:Notoginsenoside T1 is a triterpenoid.
343962-53-8 suppliers list
Company Name: EMMX Biotechnology LLC  
Tel: 888-539-0666
Website: www.emmx.com
Company Name: Chengdu Caoyuankang Biological Technology Co., Ltd.  
Tel: 13438898246
Website: www.caoyuankang.cn
Company Name: cjbscvictory  
Tel: 13348960310 13348960310
Website: https://www.weikeqi-biotech.com/
Company Name: Foshan Treasure Biotechnology Co., Ltd  
Tel: 0757-85921206 18520245316
Website: http://www.fsbn-bio.com/
Company Name: INDOFINE Chemical Company, Inc.  
Tel: 1 888 463 6346
Website: www.indofinechemical.com
Company Name: FortopChem Technology Limited   
Tel: +852 2710-8200 ex 85781
Website: www.fortopchem.com
Tags:343962-53-8 Related Product Information
80418-24-2 5302-45-4 575446-95-6 88122-52-5 88105-29-7 88100-04-3 80418-25-3 948046-15-9 80930-74-1
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept